Delivery Order SPE2DB22D3010-SPE2DB24FP2ZE

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,537.60, is for the procurement of Repatha (140 mg/mL) SureClick injectors. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award, valued at $5,308.47, is for the supply of Repatha (evolocumab) 140 mg/mL SureClick injectors. This IDC, worth up to $999,999,999 through December 2025, enables the DLA to procure a comprehensive range of medical commodities, including pharmaceuticals, to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Repatha 140 mg/mL SureClick injection medication. The contract has a firm fixed price of $1,098.00 and a period of performance through April 17, 2025. The contract is not set aside and allows for the delivery of a range of pharmaceutical products to support military and government healthcare programs. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Repatha 140 mg/mL SureClick injection medication. The contract has a ceiling value of $2,516.70 and an ultimate completion date of July 3, 2025. It is a firm fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick injectors. The $1,355.76 firm-fixed-price contract has a completion date of September 9, 2024. This award is not associated with a specific set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 for a broad range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/ml SureClick injectors. The contract has a ceiling value of $14,744.32 and an ultimate completion date of December 18, 2024. It is a firm-fixed-price contract and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha (evolocumab) 140 mg/mL SureClick injector pens. The contract has a ceiling value of $2,969.96 and an ultimate completion date of April 5, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Repatha 140 mg/mL SureClickTM injections. The contract has a ceiling value of $23,846.06 and a performance period through March 26, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Repatha (140 mg/mL SureClick). The contract has a firm fixed price of $1,041.42 and a period of performance through May 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,909.24 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick Injector, a specialty medication used to treat cardiovascular conditions. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB24FP2ZE
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $2,559.06, is for the supply of Repatha 140 mg/mL SureClick injectors, a specialty pharmaceutical product. The order is placed under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, which enables the agency to efficiently procure a wide range of medical commodities, including prescription drugs, to support military treatment programs and facilities worldwide. The contract has a firm fixed-price pricing type and an ultimate completion date of August 6, 2024. This award does not have a set-aside designation.

Generated 11/4/24, 10:30 AM